IDEXX LABORATORIES INC /DE (IDXX) Risk Factors
Health CareLatest 10-K filed Feb 20, 2026Source: SEC EDGAR
WealthWire extracted and classified 28 risk factors from IDEXX LABORATORIES INC /DE’s latest SEC filing, mapping each to a standardized risk taxonomy so they can be compared across every company and sector. The breakdown below shows how those disclosures distribute across risk categories.
Market & business
6 factorsOperations & people
6 factorsESG & reputation
5 factorsFinancial
4 factorsLegal & regulatory
4 factorsTechnology
3 factorsRecent key developments
Concrete developments — dated events, named agreements and instruments, legal proceedings — that IDEXX LABORATORIES INC /DE surfaced in its latest filing.
- Maine law prohibits sale of non-exempt products containing intentionally-added PFAS after January 1, 2032, unless Maine Department of Environmental Protection makes an unavoidable use determination.January 1, 2032
- European Union Artificial Intelligence Act enacted August 2024, establishing requirements for AI and machine learning products; fully effective August 2026, with some provisions effective February 2025.August 2024
- Japan enacted AI-related legislation in May 2025.May 2025
- U.S. administration issued executive order in December 2025 establishing federal policy aimed at curbing state-level AI-related legislation.December 2025
- Planned CEO transition in May 2026 announced on January 13, 2026.January 13, 2026
- EU-U.S. Data Privacy Framework adequacy decision adopted in July 2023 is subject to review by the European Court of Justice.July 2023
Go deeper on IDXX
This page shows the category breakdown of the latest filing. The WealthWire API and dashboard add the full risk-factor text, multi-year trends, sector comparisons, and CSV export — for IDXX and every other S&P 500 company.